Changes in the neutrophil count. by Lu Yang (30847)

“…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”

Changes in the platelet count. by Lu Yang (30847)

“…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”

Changes in the white blood cell count. by Lu Yang (30847)

“…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”

Changes in the hemoglobin. by Lu Yang (30847)

“…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”

WBC and ANC on day 7 post-chemotherapy. by Lu Yang (30847)

“…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”

General clinical data of 88 patients with NPC. by Lu Yang (30847)

“…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”

CONSORT participant flow diagram. by Lu Yang (30847)

“…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”

S4 File - by Lu Yang (30847)

“…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”

Green Hydrogen Economy: Scenarios versus Technologies by Hua Fan (495346)

“…Historical trends in LCOH indicate that lower off-grid renewable electricity costs are pivotal in decreasing production expenses, whereas electrolysis efficiencies remain relatively constant. …”

Duration of rats’ social behaviors and ultrasonic calls at the light-to-dark transition sessions. by Piotr Popik (292215)

Duration of rats’ social behaviors and ultrasonic calls at the dark-to-light transition sessions. by Piotr Popik (292215)

Measurement of Na⁺ ratio in the TE and blastocyst cross-sectional area in the ouabain-treated group. by Ayaka Fujishima (21221913)

“…The Na⁺ concentration patterns were categorized into two main types: a decrease followed by an increase (Embryo Nos. 1, 3, 7, 9), and no significant change in Na⁺ concentration (Embryo Nos. 2, 4, 6, 8). …”

In vivo combination activity of AMG 510 and pemigatinib in epithelial-like or mesenchymal-like phenotype lung cancer PDX models. by Angela Abdollahi (15166230)

Summary statistics of key variables. by Saul Estrin (8629173)

“…We propose that, while there are still agglomeration benefits, the development path followed by cities in developing countries also creates significant agglomeration costs and these act to limit innovation. …”

Fig 3 - by Aihong Zheng (20571034)

Subjects:

Landmark prospective studies on the impact of T classification and LN involvement on the survival of AC. by Aihong Zheng (20571034)

Subjects:

S1 Fig - by Aihong Zheng (20571034)

Subjects:

A brief illustration of the revisions between AJCC TNM eighth and ninth editions. by Aihong Zheng (20571034)

Subjects:

Baseline clinical and treatment features of patients with LLA ASCC. by Aihong Zheng (20571034)

Subjects:

Fig 4 - by Aihong Zheng (20571034)

Subjects: